Medstreaming has acquired M2S. Financial terms weren’t announced. Altaris Capital Partners was the seller. West Lebanon, New Hampshire-based M2S provides registry software technology which aims to improve healthcare quality. Berkery, Noyes & Co. LLC advised M2S while KeyBank Capital Markets Inc provided financial advice to Medstreaming.
Medstreaming, a leading provider of innovative healthcare cardiovascular and radiology workflow software solutions, today announced the acquisition of M2S, a leading provider of registry software technology designed for healthcare quality improvement. The combined organizations will service over 1,750 enterprise hospitals and physician office practices across the US and internationally. It will provide IT solutions designed to create workflow efficiencies and bring insights to healthcare providers and patients across the disease continuum of care.
“This acquisition will enable the creation of new breakthrough healthcare informatics technologies which allow clinical workflow to automatically aggregate registry data”, said Wael Elseaidy, Medstreaming co-founder and CEO. “These enabling technologies will marry multiple registries within the clinical workflow and fully automate registry data submission, creating significant efficiency and productivity benefits for users across the care continuum. Through the use of point-of-care data entry and personalized real-time outcome reporting, we are entering a new era of healthcare IT.”
Medstreaming plans to integrate its Graphic Fusion Workflow™ into the M2S registry applications to create a more user-friendly data sharing ecosystem. The goal is to create a governed global data platform for disease management where providers, patients, clinical researchers, medical device and pharmaceutical companies, and regulators can leverage the same platform to address the most challenging issues in healthcare today. Through collaboration within a single platform, all healthcare stakeholders will benefit as the ecosystem matures and the data set grows over time.
In addition, Medstreaming will integrate its new big data analytics technology into the M2S registry offering, enabling users to accelerate discovery and perform breakthrough data analysis. The addition of Medstreaming’s big data analytics to the M2S registry platform will unleash a new wave of innovation. The platform will apply new findings, while extending best practice information and guidelines to the point of patient care. It will also create the opportunity to fully integrate clinical research, clinical trials and post market surveillance into the registry offering. This solution will enable the registry-governed data to grow exponentially in value.
“Registry data presents a clean, controlled data set when compared to other data sources in healthcare IT; hence, it must be the gold standard for care guidelines. We intend to integrate our new real-time dynamic workflow based registry platform into all major enterprise EMR’s to facilitate better care through integrated best practices,” said Elseaidy.
“With over 20 years combined experience dedicated to the development of disruptive healthcare technologies, we will leverage the talent of both organizations to better serve our customers,” said Greg Lange, M2S CEO. “We are excited about our future.”
“M2S’s impressive team, extensive list of clients and users, and innovative registry software applications compliment the Medstreaming’s organization and our vision,” said Michael Thompson, Medstreaming’s chief operating officer. “We have had the opportunity to get to know Greg and his organization closely over the last four years. When the opportunity to bring M2S into the Medstreaming organization was presented to Medstreaming, it was only viewed as a natural progression of the successful relationship we have built together.
“We are thrilled to have Greg and the M2S team join us. Together we are well positioned to scale globally as we continue to build our disease management ecosystem,” Thompson concluded.
Berkery, Noyes & Co., LLC served as the exclusive financial advisor to M2S and KeyBank Capital Markets Inc. served as the exclusive financial advisor to Medstreaming.
Many challenges confront the medical industry due to an extremely fragmented data management environment. To address this fragmentation, Medstreaming created a Specialty-Based Cardiovascular, Vascular, and Radiology health workflow application which functions as a high performance layer in the inpatient workflow, tightly integrated with electronic medical records (EMR). Using this clinical workflow expertise, Medstreaming has also developed the industry’s first “All in One” integrated platform application that runs as an outpatient EMR, image management & reporting, and practice management workflow solution. All Medstreaming solutions act as aggregators for structured and non-structured clinical data, which in turn creates powerful data service offerings for multi-purpose, web based, data mining and data analytics. Medstreaming is headquartered in Redmond, WA. For more information, visit http://www.medstreaming.com.
M2S provides technology and services to the healthcare industry to manage clinical information, reduce costs, and improve the quality of patient care. Our extensive experience in medical imaging, data management, and outcomes analysis has positioned us as the leader in providing cost-effective, innovative healthcare performance management solutions to our customers. Through our M2S PATHWAYS clinical data performance platform, we support multiple medical specialty societies and their members by providing comprehensive tools for clinical data management, clinical outcomes assessment, and research needs. This secure, cloud-based solution enables physicians, institutions, and researchers to collect, manage, analyze, and disseminate their clinical data to achieve optimal outcomes. For more information, see http://www.m2s.com.
About Berkery Noyes
Berkery Noyes is a leading independent investment bank providing mergers & acquisitions and capital raising advisory services to middle-market companies in the healthcare, information, and technology markets. Berkery Noyes has advised many notable healthcare information technology companies including The Wellness Network in its sale to Wafra Partners, Medworxx Solutions in its sale to Aptean, Heartbeat Experts in its sale to Truven Health Analytics, Amirsys in its sale to Elsevier, AfterMath Claim Science in its sale to Equian, Therapeutic Research in its sale to Francisco Partners, Healthx in its majority recapitalization by Frontier Capital, Relsys in its sale to Oracle, Strata Decision Technology in its sale to Veronis Suhler Stevenson, HCPro in its sale to The Riverside Company, and UpToDate in its sale to Wolters Kluwer. For information, visitwww.berkerynoyes.com.